Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 7

Results: 28

Assessment of cisplatin-induced nephrotoxicity and its associated factors among cervical cancer patients in the leading tertiary hospital in Kenya.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1603, doi. 10.1177/10781552221119417

By:

Isaaka, Joshua;
Degu, Amsalu;
Kimani, Lawrence M

Publication type:

Article

Cost-effectiveness of biweekly cetuximab plus chemotherapy in first-line treatment for RAS wild-type metastatic colorectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1674, doi. 10.1177/10781552221114300

By:

Giuliani, Jacopo

Publication type:

Article

Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1613, doi. 10.1177/10781552221112320

By:

Shockley, Abigail;
Davis, James A;
Gaffney, Kelly J;
Smith, Deidra;
Weeda, Erin;
Hashmi, Hamza

Publication type:

Article

Pentosan polysulfate for the treatment of hemorrhagic cystitis after allogeneic hematopoietic cell transplant.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1609, doi. 10.1177/10781552221105295

By:

Hatch, Rachel V;
Freyer, Craig W;
Carulli, Alison;
Luger, Selina M;
Martin, Mary E;
McCurdy, Shannon R;
Porter, David L;
Loren, Alison W

Publication type:

Article

Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1624, doi. 10.1177/10781552221094308

By:

Keisner, Sidney Veach

Publication type:

Article

Role of sacituzumab govitecan in solid tumors.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1617, doi. 10.1177/10781552221092359

By:

Veeraballi, Sindhusha;
Khawar, Zaineb;
Aslam, Hafiz Muhammad;
Muzaffar, Mahvish

Publication type:

Article

Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1671, doi. 10.1177/10781552221078285

By:

Tas, Faruk;
Sakar, Burak

Publication type:

Article

Pericardial effusion with pembrolizumab.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1664, doi. 10.1177/10781552221077974

By:

Fernández Madrigal, Laura;
Montero Pérez, Olalla;
Rodriguez Garcés, Maria Yeray;
Inoriza Rueda, Ángel;
Martínez Marcos, Francisco Javier

Publication type:

Article

Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1659, doi. 10.1177/10781552221077956

By:

Garrido, David;
Riva, Eloísa

Publication type:

Article

Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.

Published in:

2022

By:

Asawa, Palash;
Chahine, Zena;
Vusqa, Urwat;
Samhouri, Yazan;
Fazal, Salman

Publication type:

Case Study

Reversible Cardiomyopathy after Rituximab Treatment in a Chronic Lymphocytic Leukemia Patient.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1650, doi. 10.1177/10781552221077422

By:

Girkar, Nishat;
Zaki, Saba;
Pawar, Sunita;
Dhande, Priti

Publication type:

Article

Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1645, doi. 10.1177/10781552221077418

By:

Caner, Burcu;
Ertas, Hulya;
Ocak, Birol;
Cubukcu, Erdem

Publication type:

Article

Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatin.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1641, doi. 10.1177/10781552221077038

By:

Varghese, Diana;
Castelino, Renita;
Simha, Vijay;
Krishnamurthy, Manjunath Nookala;
Gota, Vikram

Publication type:

Article

Successful administration of mitotane (O, p′-DDD) in pediatric oncology.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1637, doi. 10.1177/10781552221076795

By:

Strobbe, Geoffrey;
Fraipont, Félicie;
Raimbault, Sandra;
Mercier, Sylvie;
Stala, Thibault;
Naveau, Marie;
Villain, Alexandre;
Sakji, Ilyes;
Defachelles, Anne-Sophie;
Feutry, Frédéric;
Marliot, Guillaume

Publication type:

Article

Retreatment with full-dose cytarabine in a patient with previous neurological toxicity.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1634, doi. 10.1177/10781552221076777

By:

Casasnovas, Núria Meca;
Manzaneque, Alba;
Muntañola, Ana;
Castells, Genís

Publication type:

Article

Use of nab -paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1594, doi. 10.1177/10781552211038677

By:

Chen, Angela;
Ha, Vincent H;
Ghosh, Sunita;
Chambers, Carole R;
Sawyer, Michael B

Publication type:

Article

Analysis of chemical contamination by hazardous drugs with BD HD Check ® system in a tertiary hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1583, doi. 10.1177/10781552211038518

By:

Valero García, Silvia;
Centelles-Oria, María;
Palanques-Pastor, Tomás;
Vila Clérigues, Nieves;
López-Briz, Eduardo;
Poveda Andrés, José Luis

Publication type:

Article

Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1573, doi. 10.1177/10781552211038241

By:

Díaz-Acedo, Rocío;
Artacho Criado, Silvia;
Jiménez Galán, Rocío;
Gutiérrez Pizarraya, Antonio;
Galván Banqueri, Mercedes;
Rodríguez-de-la-Borbolla-Artacho, María;
Marcos Rodríguez, José Antonio;
Márquez Saavedra, Esther

Publication type:

Article

Assessing febrile neutropenia outcomes in patients receiving primary versus secondary prophylactic G-CSF treatment therapy with intermediate neutropenic risk chemotherapy regimens.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1568, doi. 10.1177/10781552211035739

By:

Goodin, Claire;
Ratliff, Patrick;
Cottingham, Lauren;
Shely, Ryan

Publication type:

Article

Oncologists' attitudes towards prophylaxis of cancer associated venous thromboembolism: A prospective, descriptive study.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1560, doi. 10.1177/10781552211035704

By:

Kandemir, Esin Aysel;
Bayraktar-Ekincioglu, Aygin;
Kilickap, Saadettin

Publication type:

Article

Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1552, doi. 10.1177/10781552211035695

By:

Dubromel, Amélie;
Caffin, Anne-Gaëlle;
Hacard, Florence;
Vantard, Nicolas;
Baudouin, Amandine;
Herledan, Chloé;
Larbre, Virginie;
Schwiertz, Vérane;
Nosbaum, Audrey;
Pralong, Pauline;
Nicolas, Jean-François;
Berard, Frédéric;
Rioufol, Catherine;
Ranchon, Florence

Publication type:

Article

Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1543, doi. 10.1177/10781552211035368

By:

Feral, Aurelie;
Boone, Mathieu;
Lucas, Virginie;
Bihan, Céline;
Belhout, Mohamed;
Chauffert, Bruno;
Lenglet, Aurelie

Publication type:

Article

Effects of piperacillin/tazobactam or cefepime on folinate dose in patients receiving high-dose methotrexate: A retrospective cohort study using Japanese administrative claims data.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1534, doi. 10.1177/10781552211034703

By:

Kadomura, Shota;
Imai, Shungo;
Momo, Kenji;
Sato, Yuki;
Kashiwagi, Hitoshi;
Itoh, Tatsuya;
Sugawara, Mitsuru;
Takekuma, Yoh

Publication type:

Article

What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1524, doi. 10.1177/10781552211031962

By:

Gilluley, Nikki;
Bennie, Marion;
Elliott, Ben

Publication type:

Article

Current status of biosimilars in Turkey: A survey among medical oncologists.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1516, doi. 10.1177/10781552211031643

By:

Gürler, Fatih;
Kasım, Demet Döndü;
Kurt İnci, Bediz;
Sütçüoğlu, Osman;
Ünsal, Oktay;
Aslan, Volkan;
Tahtacı, Gözde;
Özdemir, Nuriye;
Üner, Aytuğ;
Günel, Nazan;
Özet, Ahmet;
Yazıcı, Ozan

Publication type:

Article

Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1508, doi. 10.1177/10781552211030682

By:

Levin, Galit;
Sessink, Paul JM

Publication type:

Article

Implementation of a clinical pharmacist-led service to optimize management of refractory chemotherapy-induced nausea and vomiting in adult hematology/oncology clinic.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1499, doi. 10.1177/10781552211029702

By:

Quinn, Caroline S;
Bergsbaken, Jason J;
Blessinger, Emily J;
Piccolo, Jennifer K

Publication type:

Article

Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1487, doi. 10.1177/10781552211023571

By:

ML, Hao;
T, Wang;
JQ, Zhu;
YJ, Song;
TJ, Gong;
LK, Zou;
J, Liu;
JF, Yan

Publication type:

Article